Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations
In the media » Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations
BrainsWay Chief Medical Officer, Dr. Aron Tendler, describes to HIT Consultant the landscape of modern treatment options for patients that do not sufficiently benefit from medication and therapy.
